Curative PPO Plus
Curative PPO
Curative EPO
Dr. Xiaolin Zheng, MD
Physical Medicine & Rehabilitation*
Age 42
Be the first to review this provider!
Dr. Xiaolin Zheng, MD
Be the first to review this provider!
Flushing, NY
Accepting new patients
Clinical Overview
Dr. Xiaolin Zheng, MD works in Flushing, NY as
COMPARE OTHER TOP Physiatrists
Contrast Dr. Zheng with other nearby specialists practicing at New York-Presbyterian Hospital.
Make an appointment at New York-Presbyterian Hospital today at (212) 235-1529.
Make an appointment at New York-Presbyterian Hospital today at (212) 235-1529.
Dr. Farah Hameed, MD
Learn More
Dr. Prabhav Deo, MD
Learn More
Dr. Paul Haffey, DO
Learn More
Dr. Samantha Erosa, MD
Learn More
Dr. Michael Nicoletti, MD
Learn More
Dr. Jason Chang, MD
Learn More
These providers are on the medical staff of New York-Presbyterian Hospital.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Harvard Pilgrim Health Care PPO
-
Cigna PPO
-
Select
-
Blue Card PPO
-
First Health (Coventry Health Care) PPO
-
National (BlueCard) PPOEmpire (Select Network)-NY POS
-
Personal Choice PPO
Office Locations
-
Union Plaza Care Center3323 Union St, Flushing, NY 11354
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Zheng?
Step 1 of 3
Your review of Dr. Xiaolin Zheng, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Languages Spoken
Cantonese
Mandarin
Specialties*
Physical Medicine & Rehabilitation
Acupuncture
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Xiaolin Zheng, MD accepts new patients on Medical News Today.
Dr. Zheng accepts Curative, Harvard Pilgrim Health Care, Cigna, Aetna, Blue Cross Blue Shield, First Health, Anthem and Amerihealth as well as many others. See all of the insurances Dr. Zheng accepts here.
Dr. Zheng's office is located at 3323 Union St Flushing, NY 11354. Get a map and directions to Dr. Zheng's office here.
Yes, Dr. Zheng speaks Cantonese and Mandarin. See Dr. Zheng's profile on MedicalNewsToday for more information.
Dr. Zheng does not have any reviews yet.
Dr. Zheng is board certified in
Education & Credentials
Board Certifications
- Physical Medicine & Rehabilitation
Claim Your Profile
Are you Dr. Xiaolin Zheng, MD?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting that it may help reverse predicted biological aging.
A recent study has found that elevated NT-proBNP levels could help predict the risk of heart disease in older adults. Experts weigh in on whether the test could eventually have a role in routine cardiovascular risk assessment.
Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the treatment of lung cancer in early trials.
